THE ROLE OF ANTIOXIDANT THERAPY IN EXPERIMENTAL PHARMACOLOGICAL CORRECTION OF NEPHROLITHIASIS
https://doi.org/10.24884/1561-6274-2010-14-4-53-58
Abstract
THE AIM. The study was undertaken to study the influence of α-tocopherol acetate, a classical anti-oxidant, in the course of experimental nephrolithiasis. MATERIAL AND METHODS. Wistar male rats for 3 weeks were given as a drink 1% solution ethylene glycol, then, within the next 3 weeks, amid continued use of ethylene glycol the oil solution of б-tocopherol acetate 300 mg / kg was injected. In the urine collected per day, measured the concentration of oxalate, calcium and phosphate, pH of urine and the activity of marker enzymes lactatdehydorgenase (LDH), γ-glutamyltransferase (GGT) and N-acetyl-β-D-glucosaminidase (NAG). On the 24-th and 42-th days of the experiment was determined by the activity rate of free radical oxidation in the rat kidney. Histochemical method by Coss has been used for determination calcium-positive deposits on kidney slices of rats. RESULTS. Application of α-tocopherol acetate caused significant relief during the trial of nephrolithiasis. To a large extent suppressed by oxidative stress, decreased to normal values of the activity of marker enzymes, more than 60% decreased the concentration in urine oxalate ions, and decreased to the level corresponding to the healthy rats, the concentration in urine of calcium ions. In addition, рН urine it was displaced in an alkaline side. These changes resulted in a significant decrease in the number and size of calcium deposits in the kidneys. CONCLUSION. As a result of experiments established the important role of antioxidant therapy in the pharmacological correction of experimental nephrolithiasis.
About the Authors
A. Yu. ZharikovRussian Federation
O. S. Talalaeva
Russian Federation
Ya. F. Zverev
Russian Federation
V. V. Lampatov
Russian Federation
O. V. Azarova
Russian Federation
A. V. Kudinov
Russian Federation
Yu. G. Motin
Russian Federation
References
1. Жариков АЮ, Зверев ЯФ, Брюханов ВМ, Лампатов ВВ. Механизм формирования кристаллов при оксалатном нефролитиазе. Нефрология 2009; 13 (4): 37-50
2. Зверев ЯФ, Жариков АЮ, Брюханов ВВ, Лампатов ВВ. Модуляторы оксалатного нефролитиаза. Ингибиторы кристаллизации. Нефрология 2010; 14 (1): 29-49
3. Sumitra K, Pragasam V, Sakthivel R et. al. Benefecial effect of vitamin E supplementation on the biochemical and kinetic properties of Tamm–Horsfall glycoprotein in hypertensive and hyperoxaluric patients. Nephrol Dial Transplant 2005; 20: 1407-1415
4. Зверев ЯФ, Брюханов ВМ, Талалаева ОС и др. О роли процессов свободно-радикального окисления в развитии экспериментального нефролитиаза. Нефрология 2008; 12 (1): 58-63
5. Жариков АЮ, Брюханов ВМ, Зверев ЯФ, Лампатов ВВ. Современные методы моделирования оксалатного нефролитиаза. Нефрология 2008; 12 (4): 28-35
6. Chen DH, Kaung HL, Miller CM et al. Microarray analysis of changes in renal phenotype in the ethylene glycol rat model of urolithiasis: potential and pitfalls. BJU Int 2004; 94 (4): 637-650
7. Hadjzadeh MA, Khoei A, Hadjzadeh Z, Parizady M. Ethanolic extract of nigella sativa L seeds on ethylene glycol-induced kidney calculi in rats. Urol J 2007; 4 (2): 86-90
8. Maruch D. Rapid colorimetric assay of в-galactosidase and N-acetyl-в-glucosaminidase in human urine. Clin Chim Acta 1976; 73: 453-446
9. Голованова ОА, Борбат ВФ. Почечные камни. Мед. книга, М., 2005; 172
10. Poore RE, Hurst CH, Assimos DG, Holmes RP. Pathways of hepatic oxalate synthesis and their regulation. Am J Physiol 1997; 272 (1): 289-294
11. Зверев ЯФ, Брюханов ВМ, Лампатов ВВ, Жариков АЮ. Современные представления о роли физико-химических факторов в патогенезе кальциевого нефролитиаза. Нефрология 2009; 13 (1): 39-50
Review
For citations:
Zharikov A.Yu., Talalaeva O.S., Zverev Ya.F., Lampatov V.V., Azarova O.V., Kudinov A.V., Motin Yu.G. THE ROLE OF ANTIOXIDANT THERAPY IN EXPERIMENTAL PHARMACOLOGICAL CORRECTION OF NEPHROLITHIASIS. Nephrology (Saint-Petersburg). 2010;14(4):53-58. (In Russ.) https://doi.org/10.24884/1561-6274-2010-14-4-53-58